PBS140: new competition in the organ preservation market?
PBS140 offers good cold preservation in renal transplantation and now, crucially, has been shown to promote immediate function following warm ischemia. For a new cold preservation solution to compete with UW solution, improved efficacy and lower price may not be enough. Reducing rates of delayed graft function in organs from non-heart-beating and marginal donors might be the key.
Jamieson
R W
RW
Nuffield Department of Surgery, University of Oxford, Oxford, UK.
Friend
P J
PJ
D000241:Adenosine; D000493:Allopurinol; D003365:Costs and Cost Analysis; D005978:Glutathione; D006801:Humans; D007328:Insulin; D016030:Kidney Transplantation; D009926:Organ Preservation / Q000191:economics / Q000379:methods*; D019188:Organ Preservation Solutions / Q000191:economics; D011887:Raffinose; D014019:Tissue Donors
D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose